Standex International (SXI) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
2 Feb, 2026Executive summary
Q2 FY26 sales rose 16.6% year-over-year to $221.3M, with 6.4% organic growth, record order intake of $231M, and strong contributions from new products and fast growth markets.
Electronics segment led with 11.1% organic growth and a book-to-bill of 1.08; Engineering Technologies grew 35.3% mainly from acquisitions.
Adjusted operating margin expanded 30 bps to 19.0%; adjusted EPS up 8.9% to $2.08; net income from continuing operations (GAAP) was $20.6M.
New product sales rose 13% to $16.3M, and fast growth markets contributed 28% of total sales.
Recent acquisitions, including McStarlite and Amran/Narayan Group, significantly boosted sales and backlog.
Financial highlights
Adjusted gross margin improved 120 bps to 42.1%; adjusted operating margin up 30 bps to 19.0%; adjusted EBITDA margin 21.3%.
Free cash flow was $13.0M, up from $2.2M a year ago; operating cash flow for six months was $37.5M.
Paid down ~$10M in debt; net leverage ratio reduced to 2.3x; net debt at $437.7M.
Dividend per share increased 6.3% year-over-year to $0.34; 246th consecutive quarterly dividend declared.
Backlog under one year increased 18.1% YoY to $282.1M, mainly from acquisitions.
Outlook and guidance
FY26 sales outlook reiterated; revenue expected to grow by over $110M from 2025, with mid-to-high single digit organic growth in Electronics and double-digit growth in Engineering Technologies.
New product sales expected to reach $85M, contributing ~300 bps to sales growth; over 15 new products to be launched.
Fast growth market sales projected to exceed $270M, up 45% year-over-year.
Q3 FY26 guidance: mid-to-high single digit organic growth, higher revenue, and slightly higher adjusted operating margin.
Capital spending for FY26 projected at $33M–$38M; depreciation and amortization expected at $24M–$26M.
Latest events from Standex International
- Record profit, margin gains, and new launches set up >20% fast market growth for FY25.SXI
Q4 20242 Feb 2026 - Record margin and a $462M acquisition set the stage for sequential growth.SXI
Q1 202518 Jan 2026 - Record sales and margins driven by acquisitions, but net income and cash flow declined.SXI
Q2 20259 Jan 2026 - Record margins and 17.2% sales growth driven by acquisitions and fast growth markets.SXI
Q3 202523 Dec 2025 - Proxy covers director elections, pay, governance, risk, and ESG, with all proposals recommended.SXI
Proxy Filing1 Dec 2025 - Annual meeting covers director elections, incentive plan, pay, by-law, auditor, and ESG focus.SXI
Proxy Filing1 Dec 2025 - 2025 meeting covers director elections, say-on-pay, auditor ratification, and ESG priorities.SXI
Proxy Filing1 Dec 2025 - Shareholders will vote on a By-Law Amendment needing 80% approval, with Board support.SXI
Proxy Filing1 Dec 2025 - Record Q4 sales and margin expansion set up $100M+ revenue growth and new launches in FY26.SXI
Q4 202516 Nov 2025